Therapeutic Areas
-
![]()
Gout
Treat the pain and inflammation locally, improving gout patient outcomes
-
![]()
Post Operative Pain
Alleviate patient suffering from acute pain while mitigating the risks associated with current therapies
-
![]()
Muscle Spasms
Target the site of action of muscle spasms by delivering muscle relaxants locally
-
![]()
Diabetic Circulatory Insufficiency
Restore vasodilation and increase circulation to affected areas
-
![]()
Joint Inflammation
Target joints locally to deliver effective inflammation therapeutics safely for patients with chronic inflammation
Pipeline
Gout
Post Operative Pain
Joint Inflammation
Diabetic Circulatory Insufficiency
Muscle Spasms
In Vitro
In Vivo
POC
Phase I
Phase 2
Phase 3
Registered
Technology
Novilla’s technology leverages a specific proprietary combination of a specialized class of ionic liquids called Deep Eutectic Solvents, which had not been applied in the biotechnology industry previously. This technology delivers, through a non-invasive transdermal cream, an adequate amount of therapeutic locally while avoiding systemic effects.